211 related articles for article (PubMed ID: 32885378)
1. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps.
Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H
Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378
[TBL] [Abstract][Full Text] [Related]
2. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
5. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis.
Choi TW; Kim JH; Yu MH; Park SJ; Han JK
Acta Radiol; 2018 Apr; 59(4):383-392. PubMed ID: 28766979
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the World Health Organization Grade of rectal neuroendocrine tumors based on CT histogram analysis.
Liang P; Xu C; Tan F; Li S; Chen M; Hu D; Kamel I; Duan Y; Li Z
Cancer Med; 2021 Jan; 10(2):595-604. PubMed ID: 33263225
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
14. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade.
Kim JH; Eun HW; Kim YJ; Han JK; Choi BI
Abdom Imaging; 2013 Oct; 38(5):1106-14. PubMed ID: 23728305
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
Ren S; Chen X; Wang J; Zhao R; Song L; Li H; Wang Z
Abdom Radiol (NY); 2019 Mar; 44(3):867-876. PubMed ID: 30293109
[TBL] [Abstract][Full Text] [Related]
16. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.
Besa C; Ward S; Cui Y; Jajamovich G; Kim M; Taouli B
J Magn Reson Imaging; 2016 Dec; 44(6):1432-1441. PubMed ID: 27227756
[TBL] [Abstract][Full Text] [Related]
18. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.
Lotfalizadeh E; Ronot M; Wagner M; Cros J; Couvelard A; Vullierme MP; Allaham W; Hentic O; Ruzniewski P; Vilgrain V
Eur Radiol; 2017 Apr; 27(4):1748-1759. PubMed ID: 27543074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
